Predicting prostate biopsy results: The importance of PSA, age, and race

American Journal of Clinical Pathology

Volumn 126, Issue 1, 2006, Pages 110-112

  Grunkemeier, M Natalie ^a   Vollmer, Robin T ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Age; Probability; Prostate cancer; Prostate specific antigen; Race

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE; ARTICLE; BLOOD LEVEL; CANCER INCIDENCE; DECISION MAKING; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE; SENSITIVITY AND SPECIFICITY; UNIVARIATE ANALYSIS;

EID: 33745799033     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/PXV2VMB32EC789DA     Document Type: Article

References (18)

1. Catalona WJ, Hudson MA, Scardino PT, et al. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J Urol. 1994;152:2037-2042.
2. El-Galley RES, Petros JA, Sanders WH, et al. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma. Urology. 1995;46:200-204.
3. Morgan TO, Jacobsen SJ, McCarthy WF, et al. Age-specific reference ranges for serum prostate-specific antigen in black men. N Engl J Med. 1996;335:304-310.
4. Anderson JR, Strickland D, Corbin D, et al. Age-specific reference ranges for serum prostate-specific antigen. Urology. 1995;46:54-57.
5. Jacobsen S, Bergstralh EJ, Guess HA, et al. Predictive properties of serum prostate-specific antigen testing in a community-based setting. Arch Intern Med. 1996;156:2462-2468.
6. DeAntoni EP, Crawford ED, Oesterling JE, et al. Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study. Urology. 1996;48:234-239.
7. Sawyer R, Berman JJ, Borkowski A, et al. Elevated prostate-specific antigen levels in black and white men. Mod Pathol. 1996;9:1029-1032.
8. Weinrich S, Jacobsen SJ, Weinrich SP, et al. Reference ranges for serum prostate-specific antigen in black and white men without cancer. Urology. 1998;52:967-973.
9. Fowler JE, Bigler SA, Kilambi NK, et al. Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies. Urology. 1999;53:1175-1178.
10. Cooney KA, Strawderman MS, Wojno KJ, et al. Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men. Urology. 2001;57:91-96.
11. Bunker CH, Patrick AL, Miljkovic-Gacic I, et al. Prostate cancer screening parameters in a high-risk African-Caribbean population. Urology. 2004;63:737-741.
12. Henderson RJ, Eastham JA, Culkin DJ, et al. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer. J Natl Cancer Inst. 1997;89:134-138.
13. Punglia RS, D'Amico AV, Catalona WJ, et al. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med. 2003;349:335-342.
14. Smith DS, Carvalhal GF, Mager DE, et al. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men. J Urol. 1998;160:1734-1738.
15. Lodding P, Aus G, Bergdahl S, et al. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng/mL prostate specific antigen. J Urol. 1998;159:899-903.
16. Catalona WJ, Ramos CG, Carvalhal GF, et al. Lowering the PSA cutoffs to enhance detection of curable prostate cancer. Urology. 2000;55:791-795.
17. Fowler JE, Bigler SA, Farabaugh PB. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL. Cancer. 2002;94:1661-1667.
18. Vollmer RT. Predictive probability of serum prostate specific antigen for prostate cancer: an approach using Bayes rule. Am J Clin Pathol. 2006;125:336-342.